Methods Orbits underwent one of three injection techniques with bupivacaine 0.5% and iohexol (1:1): ventrolateral RB injection (1e2 mL; 15 orbits), medial canthal PB injection (2e8 mL; PB-1; 16 orbits), or dorsomedial and ventrolateral PB injections (each 1e4 mL; PB-2; 16 orbits). The likelihood of successful regional anesthesia was estimated based on computed tomographic images scored for injectate volume of distribution at the base and within the extraocular muscle cone (EOMC), and injectate distribution around the optic nerve. Intraocular pressure (IOP) was measured before and after injections. Mixed-effects linear regression with post hoc Bonferroni contrast adjustments was performed. Significance was set at 0.05.
Results A difference in injectate volume of distribution within or at the base of the EOMC was not detected among groups. The median optic nerve circumference of injectate distribution was significantly higher in the RB injected group than in the PB-2 group. Injectate distribution following RB, PB-1 and PB-2 injections was graded as likely to provide regional anesthesia within the EOMC in 40%, 19% and 31% of eyes, and at the EOMC base in 60%, 63% and 50% of eyes, respectively. The probability of likelihood to provide regional anesthesia was lower in dogs of higher body weights. The IOP was significantly higher than baseline following PB-1 (18 ± 14 mmHg) and in comparison with RB (2 ± 3 mmHg), but not different from PB-2 injection (10 ± 11 mmHg).
Introduction
In humans, retrobulbar (RB) anesthesia [injection of local anesthetic into the extraocular muscle cone (EOMC)] and peribulbar (PB) anesthesia (injection of local anesthetic outside the EOMC) produce excellent perioperative analgesia and extraocular muscle akinesia, and protect against the oculocardiac reflex (Ghali & El Btarny 2010) . The PB injection may provide better analgesia for periorbital structures, and may be safer as the needle is introduced extraconally and is less likely to cause injury to nerves and vessels that pass inside the cone (Nouvellon et al. 2010) .
It has been proposed that in dogs the RB injection provides better distribution into the orbital muscle cone than does PB injection (Accola et al. 2006) . However, in that study, the injectate volume for both techniques was 2 mL, whereas in humans the volume used for PB anesthesia is 2e4 times that used for RB anesthesia (Nouvellon et al. 2010) . Therefore, the goals of the present study were to develop a reliable method for PB injectate delivery, to describe potential complications of two PB injection techniques and to compare, in dog cadavers, the injectate volume of distribution achieved using these two PB techniques versus the distribution achieved using the more commonly used RB injection technique (Accola et al. 2006; Giuliano 2008; Hazra et al. 2008; Myrna et al. 2010) . Our hypothesis was that the distribution of injectate produced by PB and RB techniques would be similar.
Materials and methods

Preliminary investigation
To establish the injection site and the injectate volume required for PB injections, a pilot study was conducted in five dogs with terminal illnesses that were euthanized and the bodies donated by their owners for unrestricted use. Cadavers were positioned in sternal recumbency with the head elevated on a triangular block of foam to provide easy access for the injection and a good position for imaging.
A 1:1 mixture (by volume) of bupivacaine 0.5% (Kamacaine 0.5%; Kamada, Israel) and an iodinated contrast agent, iohexol (Omnipaque 300; GE Healthcare, Ireland), formed the injectate. The volume injected in each orbit was increased in 0.2 mL kg À1 increments from 0.2 to 0.8 mL kg À1 .
Computed tomography (CT) was performed to assess injectate distribution. The total volume required for optimal injectate distribution increased nonlinearly with body size. Thus, an allometric equation was developed to calculate the volume required per orbit based on dog body weight (BW) in kg: 2.33 Â BW 0.33 . In addition, injections were performed at four injection sites: ventrolateral, dorsomedial, medial canthus and ventrolateral and dorsomedial combined. The medial canthal injection site and the combined ventrolateral and dorsomedial injection sites appeared to provide the best injectate distribution and were used in the present study.
Study design
Cadavers of 24 dogs with terminal illnesses that were euthanized and donated by their owners for unrestricted use were used. All cadavers were kept at room temperature. Each orbit of all dogs was randomly assigned (www.random.org/lists/) to one of three injections: an RB injection (group RB), a single PB injection at the medial canthus (group PB-1) and two PB injections, one each in the ventrolateral and dorsomedial orbit (group PB-2). This study used the same injectate mixture that was evaluated in the preliminary study.
Injection techniques
The RB injections were performed using a technique similar to that described by Accola et al. (2006) . A 22 gauge, 8.9 cm spinal needle (Shanghai KDL Co. Ltd, Shanghai, China) was bent at the proximal end to achieve an angle of approximately 20 . The needle was inserted through the inferior eyelid at the junction of its middle and temporal thirds, and advanced until a slight popping sensation was detected. The needle was then directed slightly dorsally and nasally toward the apex of the orbit and advanced several millimeters further (depending on the dog's size). Once the needle tip was believed to be in an intraconal location, and after negative aspiration of blood or fluids was obtained, the entire volume was injected, either 1 mL ( 10 kg) or 2 mL (>10 kg). The PB injections were performed with a 25 gauge, 1.6 cm needle (DYN Medical Equipment Ltd, Israel) inserted through the eyelid and advanced to its full length in close proximity to the wall of the orbit. For both PB injections, the formula 2.33 Â BW 0.33 mL was used. For PB-1 injections, the needle was inserted at the medial canthus, and the entire calculated volume was injected. For PB-2 injections, one needle was inserted through the inferior eyelid at the ventrolateral region and the second needle was inserted through the superior eyelid at the dorsomedial region, and the total volume was divided equally between the two injection sites. Negative pressure was obtained on aspiration prior to all injections, and a slight forward pressure was applied to the needle during injection to ensure that it remained in the desired location. One anesthesiologist performed all injections (YSB). For all techniques, injections were performed with the bevel of the needle oriented toward the globe. Intraocular pressure (IOP) was estimated using applanation tonometry (Tono-Pen Vet; Reichert Technologies, NY, USA) before, immediately after and 10 minutes after each injection.
Injectate distribution assessment
Before and 10 minutes after each injection, CT was performed (Philips MX8000 IDT; Philips Medical Systems Technologies Ltd, OH, USA), and a boardcertified veterinary radiologist (ERW), who was unaware of the injection technique, assessed the volume of distribution of the local anestheticecontrast mixture. Digital images [digital imaging and communication in medicine (DICOM)] were reviewed on a workstation with commercially available medical imaging software (eFilm; MERGE Healthcare, IL, USA), and the images were reformatted as necessary to enable viewing of dorsal and oblique anatomic planes.
Apparent injectate volume of distribution at the base of the EOMC (where the optic nerve emerges from the skull) and within the EOMC (intraconally) were each assigned a score (0 ¼ none, 1 ¼ moderate, 2 ¼ large). In addition, the circumference of the optic nerve contacted by injectate was estimated to be approximately 0 , 90 , 180 , 270 or 360 . The likelihood of adequate regional anesthesia was estimated as likely, possible, or unlikely using two definitions. The first definition used the intraconal distribution score and the circumference of the optic nerve contacted by injectate: likely, when the intraconal distribution score was 2 and the extent of optic nerve contact was 270e360 ; possible, when the intraconal distribution score was 1 and extent of optic nerve contact was 90e180 ; and unlikely, when the intraconal distribution score was 0 and extent of optic nerve contact was 0 . The second definition for estimating adequate regional anesthesia used only the distribution score at the base of the EOMC: likely, when the score was 2; possible, when the score was 1; and unlikely, when the score was 0.
Statistical analysis
Mixed-effects linear regression was used to model the potential effect of injection technique on IOP and on volume of distribution scores. The individual dog was treated as a random effect, and fixed effects included orbit and injection type. A square root transformation of IOP was used to make the distribution of residuals better conform with normality. Post hoc comparisons of injection types were adjusted for multiple comparisons using the Bonferroni procedure. Mixedeffects ordinal logistic regression was used to evaluate the relationship between BW category ( or >20 kg) and injection type on the likelihood of achieving clinically successful anesthesia within or at the base of the EOMC. The proportions of orbits with injectate distribution judged likely to provide adequate regional anesthesia were presented with exact 95% binomial confidence intervals. For all analyses, p values < 0.05 were considered significant.
Results
Twenty-four fresh dog cadavers, consisting of 13 females (nine ovariohysterectomized) and 11 males (six castrated), were used. Mean ± standard deviation (SD) (range) age and BW were 12.0 ± 2.7 (5.5e17.0) years and 20.1 ± 11.1 (2.0e36.3) kg, respectively. The mean ± SD (range) time from euthanasia to injection was 107 ± 57 (40e265) minutes. Each injection technique was performed on 16 orbits; however, one injection in RB lacked a contrast agent, and this orbit was omitted from all analyses. During the PB-1 injection, the needle was inserted into the third eyelid or its gland in three out Table 1 Mean ± standard deviation (range) for intraocular pressure (mmHg) before (baseline), immediately after, and 10 minutes after retrobulbar (RB; 1e2 mL injectate, n ¼ 15), medial canthal peribulbar (PB-1; 2e8 mL injectate, n ¼ 16) or ventrolateral and dorsomedial peribulbar (PB-2; 2e8 mL injectate, n ¼ 16) injections of a 1:1 mixture by volume of iohexol and 0.5% bupivacaine into 47 orbits of 24 dog cadavers
Group Time points
Before injection
Immediately after injection
Ten minutes after injection
* Significantly different from RB at the same time point (p < 0.05). y Significantly different from baseline (p < 0.05).
of 16 (19%) orbits; in two of these cases, the malposition was noticed immediately and the needle was repositioned. With all three cases, only part of the volume was injected into the third eyelid area. Subjectively, exophthalmos was evident following all PB-1 and most PB-2 injections (14 out of 16 orbits).
The IOP values prior to injection ranged from 0 to 5 mmHg and were below the physiologic range (Table 1) . Immediately following injection, IOP increased significantly from baseline in PB-1, and was significantly different between PB-1 and RB (p < 0.001), but not between RB and PB-2 (p ¼ 0.077) or between PBA-1 and PB-2 (p ¼ 0.171). At 10 minutes after injection, the mean IOP returned toward baseline values in all eyes, except onedin PB-1 that remained at 21 mmHg.
Scores for injectate volume of distribution within and at the base of the EOMC and around the optic nerve had variable ranges with all techniques ( Table 2 ). The injectate distribution around the optic nerve was significantly less in PB-2 than in RB (p ¼ 0.025). Injectate distribution considered likely or possible to result in adequate regional anesthesia was achieved using all three injection techniques regardless of whether the intraconal or base of the EOMC definition was used (Fig. 1) . The number of dogs in which such results were achieved varied depending on technique and definition used (Table 3) . Regardless of whether the intraconal or EOMC base definition was used, no technique provided better probability for achieving adequate regional anesthesia as defined. For all techniques, the probability of likely to achieve regional anesthesia was higher in dogs weighing 20 kg; however, this difference was significant only when using the intraconal distribution definition (Table 4 ; p ¼ 0.015).
No CT evidence of intraocular, intravascular, intrathecal or intraneural injectate deposition was detected following any of the injections. Likely, intraconal distribution score of 2 and extent of optic nerve contact 270e360 , or an EOMC base distribution score of 2; possible, intraconal distribution score of 1 and extent of optic nerve contact 90e180 , or an EOMC base distribution score of 1. CI, confidence interval. 
Discussion
In the present study, none of the injection techniques reliably delivered intraconal injectate with distribution scores the authors believed necessary to likely produce adequate regional anesthesia. The first report of PB injectate distribution in dogs used four cadaver orbits each injected with 2 mL of latex material divided between two injection locations (1 mL per location): dorsal (superior) and ventral (inferior) (Accola et al. 2006) . These were deemed unsuccessful, and were omitted from further investigation. In comparison with findings in dogs by Accola et al. (2006) , distribution of 6 mL of colored latex within the EOMC following PB injections was considered excellent in 10 orbits of human cadavers (Ripart et al. 2001) . Likewise, CT evidence in cats suggested that PB injection of 4 mL bupivacaine combined with a contrast agent achieved excellent intraconal delivery in 11 out of 13 cat cadaver orbits (Shilo-Benjamini et al. 2013 ). The lack of success by Accola et al. (2006) may be related to the small volume of injectate and/or the injection location. A larger volume of injectate is required for diffusion into the EOMC when using the PB technique (Nouvellon et al. 2010 ). In addition, since the canine orbit is open laterally and somewhat open dorsally (Evans 1993; Miller 2013) , some injectate may diffuse peripherally instead of caudally. In the present study, despite the use of a larger volume and selection of injection points where the orbit is more closed, the intraconal distribution still was not consistent. For this reason, the likelihood of achieving adequate regional anesthesia was evaluated at the EOMC base in addition to the EOMC space. At the EOMC base, the ophthalmic branch of the trigeminal nerve emerges from the orbital fissure, which is adjacent to the optic nerve as it emerges from the optic foramen (Evans & Kitchell 1993) . Therefore, we hypothesized that although the intraconal distribution was lacking, if the base of the EOMC had a good distribution of injectate, then it is likely to provide regional anesthesia to the orbit. Differences in injectate distribution seen in dogs, humans and cats may be attributed to species differences. For example, humans are purported to have no membrane between the extraconal and intraconal spaces; thus, local anesthetic solution can diffuse easily from one space to the other (Ripart et al. 2001) . By contrast, dogs have retractor bulbi muscles in this location, which may alter injectate distribution relative to humans who lack retractor bulbi muscles (Miller 2013) . However, the presence of retractor bulbi muscles in dogs does not explain the difference in intraconal distribution between dogs and cats, as these muscles are present in cats. Although projected clinical success following PB injections in the present study was low, a recent experimental study in 15 dogs (30 orbits) reported clinical success (measured by decreased corneal sensitivity) following PB injection of 0.3 mL kg À1 of 1% ropivacaine injected via a ventrolateral site (Wagatsuma et al. 2014) . To better correlate data from the present study and those from clinical trials, it will require another investigation that will correlate the injectate distribution scores and the clinical effects following RB and PB injections in dogs.
The proposed clinical success of RB injections in the present study was lower than that reported in previous studies in dogs. Complete intraconal placement of injectate was evident in six out of 15 (40%) of orbits injected using the RB technique, and partial intraconal placement of injectate was evident in another five out of 15 (33%). By comparison, in the first experimental study to describe RB injection in dogs, a successful outcome was projected in all four Beagle dog cadavers (eight orbits) assessed via magnetic resonance imaging; however, based on a significant increase in horizontal pupil diameter and central rotation of the globe in four anesthetized Beagle dogs (four orbits), a 75% success rate was reported (Accola et al. 2006 ). Reported success in clinical studies varies. One study reported that 10 out of 10 (100% success) canine eyes became central following extraconal RB injection of 2 mL of 2% lidocaine prior to cataract surgery (Hazra et al. 2008) . Another study reported 82% success (nine out of 11 dogs) based on rescue analgesia being required following enucleation surgery. These dogs were administered a ventrolateral RB injection with 2e3 mL of 0.5% bupivacaine (Myrna et al. 2010) . Two other studies assessed the anesthetic effect of bupivacaine or a lidocaineebupivacaine mixture administered via a presurgical RB injection versus local infiltration at the end of enucleation (Ploog et al. 2014; Chow et al. 2015) . Considering only the dogs administered an RB injection, one out of 15 dogs in one study required rescue analgesia (93% success) (Chow et al. 2015) , whereas 0 out of 11 dogs in a second study required rescue analgesia (100% success) (Ploog et al. 2014) . Shorter and smaller gauge needles are used in humans for the PB technique in comparison to the needles used for the RB technique (Nouvellon et al. 2010) . This difference in needle size was not reported to produce any difference in the spread of the local anesthetic between these techniques in humans (Ali-Melkkil€ a et al. 1993) or in cats (Shilo-Benjamini et al. 2014) . As the PB technique relies on distribution and not on specific deposition of the injectate, then the use of a shorter and smaller gauge needle is sufficient and potentially decreases the adverse effects of the PB injection technique (El Said & Kabeel 2010).
The significantly lower probability of achieving successful regional anesthesia based on intraconal distribution with all techniques in dogs of higher BW (>20 kg) was surprising since, for the PB injection techniques, this study used an allometric method to calculate the injectate volume. In retrospect, this decrease in success may have resulted from use of the same needle length (1.6 cm) for all dogs regardless of BW. In a recent experimental study of PB injection technique in Beagle dogs, a 2.54-cm-long needle was used (Wagatsuma et al. 2014) . It is possible that, in larger dogs, longer needles may be required to deposit the injectate more caudally and achieve better distribution. For the RB injection technique, the volume used in the present study may have been too low for dogs >20 kg, as two studies have described RB administration of 3 mL in dogs >15 kg (Myrna et al. 2010; Ploog et al. 2014 ). In the study by Chow et al. (2015) , BWs are not reported but the breeds recorded would suggest that the majority of their dogs were <20 kg. A higher success rate was reported in a study of dogs limited to 10e15 kg (Hazra et al. 2008) .
The increase in IOP following PB injections, especially PB-1, recorded in the present study has also been reported in humans (Bowman et al. 1996; Ghali & El Btarny 2010) , cats (Shilo-Benjamini et al. 2013 and dogs (Wagatsuma et al. 2014) . The increase in IOP usually does not persist beyond 10 minutes, as noted in the present study. However, preinjection IOPs in the cadaver eyes used in the present study were below physiologic ranges, and normal autoregulatory mechanisms controlling IOP were absent. Therefore, further investigation is important in living animals with normal or abnormal aqueous outflow pathways. Until this information is available, based on data from the cadaver eyes, PB injection should likely be avoided in dogs with perforated globes or globes at risk of perforation, such as eyes with deep stromal ulcers, descemetoceles or corneal lacerations undergoing globe salvaging procedures. In animals with an elevated IOP, with or without glaucoma, a PB injection may be considered a relative contraindication since mild increases in IOP would be of less concern or no concern if the globe was being removed. It should be noted that the needle was inadvertently passed into or through the third eyelid or its gland in 19% of PB-1 injections. The clinical effect of this is unknown. If the injection preceded enucleation or exenteration, this would likely be of little significance since the entire third eyelid is removed during those procedures.
The present study has several limitations. First, differences in all parameters assessed would be expected between cadavers and live animals, resulting from cardiovascular effects and a normotensive globe on injectate distribution and IOP in the latter subjects. Second, the study population was small and included dogs with terminal diseases, many of whom were older, more cachectic and dehydrated than animals typically undergoing ocular surgery, and consequently enophthalmic with reduced orbital contents. Third, the proposed clinical success in the present study was defined on objective scores from CT images, which have not been correlated with analgesic effectiveness in living animals.
In conclusion, based on the definitions in the study design, the RB, PB-1 and PB-2 injection techniques produced large injectate volumes within the EOMC of 40%, 19% and 31% of orbits, and at the EOMC base in 60%, 63% and 50% of orbits, respectively. 
